IART - CIK 0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported revenue of $1.64B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $1.64B | +1.5% |
| FY 2024 | $1.61B | +4.5% |
| FY 2023 | $1.54B | -1.0% |
| FY 2022 | $1.56B | +1.0% |
| FY 2021 | $1.54B | +12.4% |
| FY 2020 | $1.37B | -9.6% |
| FY 2019 | $1.52B | +3.1% |
| FY 2018 | $1.47B | +23.9% |
| FY 2017 |
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported revenue of $1.64B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, INTEGRA LIFESCIENCES HOLDINGS CORP's revenue grew from $992.08M to $1.64B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.19B |
| +19.8% |
| FY 2016 | $992.08M | - |